Moderna

(NASDAQ) MRNA

Current Price$48.53

Market Cap$19.26B

Since IPO (2018)+161%

5 Year-70%

1 Year+102%

1 Month-3%

Moderna Financials at a Glance

Market Cap

$19.26B

Revenue (TTM)

$2.23B

Net Income (TTM)

$3.19B

EPS (TTM)

$-8.15

P/E Ratio

-5.96

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$48.53

Volume

106,296.199

Open

$51.69

Price

$48.53

Volume

106,296.199

Open

$51.69

Previous Close

$48.54

Daily Range

$47.78 - $52.00

52-Week Range

$22.28 - $59.55

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$48.53

Volume

106,296.199

Open

$51.69

Previous Close

$48.54

Daily Range

$47.78 - $52.00

52-Week Range

$22.28 - $59.55

MRNA News

research scientists drugs pharma biotech

Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth

Prosper Junior BakinyApr 21, 2026

A scientist looking through a microscope.

Best Biotech ETFs to Buy in 2026

Keith SpeightsApr 11, 2026

You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500.

Adria CiminoApr 7, 2026

Page 1

MRNA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Moderna

Industry

Biotechnology

Sector

Health Care

Employees

4,700

CEO

Stéphane Bancel, MBA

Website

www.modernatx.com

Headquarters

Cambridge, MA 02142, US

MRNA Financials

Key Financial Metrics (TTM)

Gross Margin

-14%

Operating Margin

-2%

Net Income Margin

-1%

Return on Equity

-37%

Return on Capital

-38%

Return on Assets

-28%

Earnings Yield

-16.78%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$19.26B

Shares Outstanding

396.79M

Volume

106.30K

Avg. Volume

7.82M

Financials (TTM)

Gross Profit

$1.08B

Operating Income

$3.07B

EBITDA

$2.55B

Operating Cash Flow

$1.87B

Capital Expenditure

$192.00M

Free Cash Flow

$2.06B

Cash & ST Invst.

$5.80B

Total Debt

$1.92B

Moderna Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$389.00M

+263.6%

Gross Profit

$566.00M

-3429.4%

Gross Margin

-1.46%

N/A

Market Cap

$19.26B

N/A

Market Cap/Employee

$3.32M

N/A

Employees

5,800

N/A

Net Income

$1.34B

-38.3%

EBITDA

$1.33B

-43.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$3.91B

-25.3%

Accounts Receivable

$147.00M

-52.0%

Inventory

$146.00M

+14.1%

Long Term Debt

$1.25B

+77.8%

Short Term Debt

$50.00M

+16.3%

Return on Assets

-27.80%

N/A

Return on Invested Capital

-37.52%

N/A

Free Cash Flow

$692.00M

+40.5%

Operating Cash Flow

$630.00M

+39.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

JAZZJazz Pharmaceuticals plc

JAZZJazz Pharmaceuticals plc$226.96-0.70%

BBIOBridgeBio Pharma, Inc.

BBIOBridgeBio Pharma, Inc.$67.45-0.94%

MDGLMadrigal Pharmaceuticals, Inc.

MDGLMadrigal Pharmaceuticals, Inc.$534.86-0.90%

EXELExelixis, Inc.

EXELExelixis, Inc.$46.21-5.11%

BMRNBioMarin Pharmaceutical Inc.

BMRNBioMarin Pharmaceutical Inc.$54.12-0.88%

RVMDRevolution Medicines, Inc.

RVMDRevolution Medicines, Inc.$142.51-5.67%

TECHBio-Techne Corporation

TECHBio-Techne Corporation$50.91+7.39%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.73+0.00%

NOKNokia

NOKNokia$12.35-0.06%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$694.94-0.00%

SOFISoFi Technologies

SOFISoFi Technologies$16.00-0.02%

POETPoet Technologies

POETPoet Technologies$9.58-0.01%

FSLYFastly

FSLYFastly$19.50-0.38%

Questions About MRNA

What is the current price of Moderna?

Moderna is trading at $48.54 per share.

What is the 52-week range for Moderna?

Over the past 52 weeks, Moderna has traded between $22.28 and $59.55.

How much debt does Moderna have?

As of the most recent reporting period, Moderna reported total debt of $1.30B.

How much cash does Moderna have on hand?

Moderna reported $1.91B in cash and cash equivalents in its most recent financial results.

What is Moderna’s dividend yield?

Moderna does not currently have a dividend yield.

Moderna

Moderna Financials at a Glance

MRNA News

Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth

Best Biotech ETFs to Buy in 2026

You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500.

2 Healthcare Stocks That Could Soar Over the Next 5 Years

Moderna Stock is Soaring. Is It Too Late to Buy?

Best Commercial Real Estate Stocks for 2026

Best Vaccine Stocks of 2026: Are They Right for Your Portfolio?

How to Invest in SPDR S&P Biotech ETF (XBI)

MRNA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Moderna

MRNA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Moderna Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MRNA

What is the current price of Moderna?

What is the 52-week range for Moderna?

How much debt does Moderna have?

How much cash does Moderna have on hand?

What is Moderna’s dividend yield?

Premium Investing Services